InvestSMART

XRF Scientific Limited (ASX: XRF) - Announcements

Current share price for XRF : $2.090 0.175 (9.14%)+

ASX company news and announcements for XRF Scientific Limited (XRF) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All XRF Scientific Limited (XRF) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than XRF Scientific Limited (XRF), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for XRF Scientific Limited (XRF)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$302 2014 AGM CEO Presentation 14 Nov 2014 10:11AM $0.200 $2.090 risen by 945%
$302 Coltide XRF Drift Monitors 5 Nov 2014 12:46PM $0.190 $2.090 risen by 1,000%
$302 Appendix 4E - Preliminary Final Report 22 Aug 2014 9:11AM $0.185 $2.090 risen by 1,029.73%
$302 Appendix 4D - Half-year Report 14 Feb 2014 9:27AM $0.250 $2.090 risen by 736%
$302 2013 AGM CEO Presentation 14 Nov 2013 10:26AM $0.310 $2.090 risen by 574.19%
$302 XRF Increases Shareholding in Scancia 12 Sep 2013 9:10AM $0.330 $2.090 risen by 533.33%
$302 Appendix 4E Preliminary Final Report 23 Aug 2013 8:26AM $0.320 $2.090 risen by 553.13%
$302 Kitco Labware Acquisition Update 4 Jul 2013 3:42PM $0.310 $2.090 risen by 574.19%
$302 XRF to Expand its Precious Metals Division by Acquisition 26 Jun 2013 9:06AM $0.310 $2.090 risen by 574.19%
$302 Appendix 4D - Half-year Accounts 19 Feb 2013 9:27AM $0.360 $2.090 risen by 480.56%
$302 2012 AGM CEO Presentation 15 Nov 2012 9:32AM $0.255 $2.090 risen by 719.61%
$302 Preliminary Final Report - Appendix 4E 27 Aug 2012 8:27AM $0.260 $2.090 risen by 703.85%
$302 Appointment of Chief Executive Officer 6 Aug 2012 12:53PM $0.255 $2.090 risen by 719.61%
$302 New Automation Joint Venture 27 Apr 2012 12:04PM $0.265 $2.090 risen by 688.68%
$302 Board and Management Changes 29 Mar 2012 12:59PM $0.260 $2.090 risen by 703.85%
$302 Appendix 4D - Half Year Accounts 24 Feb 2012 9:23AM $0.250 $2.090 risen by 736%
$302 2011 AGM Presentation 30 Nov 2011 12:29PM $0.210 $2.090 risen by 895.24%
$302 Preliminary Final Report - Appendix 4E 26 Aug 2011 10:08AM $0.220 $2.090 risen by 850%
$302 XRF Scientific Makes Strategic Investment 22 Aug 2011 1:45PM $0.230 $2.090 risen by 808.70%
$302 Profit Upgrade and Preliminary 2011 Results 27 Jul 2011 9:27AM $0.245 $2.090 risen by 753.06%
$302 XRF announces Placement and SPP 13 Jul 2011 9:51AM $0.225 $2.090 risen by 828.89%
$302 Trading Halt 11 Jul 2011 9:45AM $0.250 $2.090 risen by 736%
$302 Spectrolaser Sale Agreement 17 Mar 2011 8:27AM $0.185 $2.090 risen by 1,029.73%
$302 Appendix 4D - December 2010 Half Yearly Accounts 18 Feb 2011 6:59PM $0.240 $2.090 risen by 770.83%
$302 Company Update - January 2011 28 Jan 2011 12:24PM $0.200 $2.090 risen by 945%

326 - 350 of 392 results

Page 14 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.